Octean Pharma ApS: Financial statements 2023
CVR: 38023667
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 187,912 and a net result of DKK 18,824 compared with DKK 10,685 the year before. That is a decrease of 67.1% compared with the year before. Equity in the 2023 report amounted to DKK 119,663. The solvency ratio was 16.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 187,912
- Profit/Loss
- DKK 18,824
- Equity
- DKK 119,663
- Total Assets
- DKK 739,390
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 188 t. | 19 t. | 120 t. | 1 |
| 2022 | - | 571 t. | 11 t. | 101 t. | 1 |
| 2021 | - | 1.2 mio. | 43 t. | 90 t. | 1 |
| 2020 | 1.3 mio. | 793 t. | 11 t. | 47 t. | 1 |
| 2019 | 1.1 mio. | 751 t. | 51 t. | 36 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Octean Pharma ApS has published its annual report for 2022. Gross profit came to DKK 571,137, and the net result was DKK 10,685.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.